BioSpace News Archive

Policy

“RACE for Children Act” May Result in More Drugs Appropriate for Children

The U.S. government has been pushing to increase access to experimental drugs over the last two years. On August 18, 2018, the RACE for Children Act was signed into law as part of the 2017 FDA Reauthorization Act, which amended the Pediatric Research Equity Act (PREA).

January 17, 2019
·
4 min read
·
Mark Terry
Job Trends

BioSpace Movers and Shakers: Jan. 18

Pharma and biotech companies make changes to their board and leadership teams to advance pipelines and strategies, at SQZ, AstraZeneca, Bioasis, and more.

January 17, 2019
·
4 min read
·
Alex Keown
Deals

Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock at $62.00 Per Share

Mirati Therapeutics, Inc. (Nasdaq: MRTX) announced the pricing of an underwritten public offering of 1,612,903 shares of its common stock at a price to the public of $62.00 per share.

January 17, 2019
·
5 min read
Lonza Announces Initiation of S&P Credit Rating with Investment Grade of BBB+ and Stable Outlook

Lonza announced that Standard & Poor’s (S&P) assigned a BBB+ credit rating with stable outlook to Lonza.

January 17, 2019
·
3 min read
Medigene AG: Medigene participates at four upcoming conferences

Medigene AG announced its participation at the following upcoming investor and scientific conferences

January 17, 2019
·
1 min read
Business

Almac Group extends personalised cancer vaccine production facilities

The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities.

January 17, 2019
·
3 min read
Medtronic Enrolls First Patient in Clinical Study to Assess Pain Control and Oral Opioid Elimination with Targeted Drug Delivery

Study Will Further Advance Understanding of Effectiveness and Tolerability of the SynchroMed(TM) II Intrathecal Drug Delivery System in Patients Who Have Weaned off Oral Opioids

January 17, 2019
·
7 min read
Business

Cees de Jong: new Chairman of the joint start-up A-Mansia Biotech

A-Mansia Biotech, a microbiome company, has announced the appointment of Cees de Jong as the Chairman of its Board of Directors.

January 17, 2019
·
2 min read
New Data Published in PLOS ONE Demonstrates Early Therapeutic Effects of Pharnext’s PLEODRUG(TM) PXT3003 in a Transgenic Rat Model of Charcot-Marie-Tooth disease Type 1A

Pharnext SA announced the publication of new preclinical results for its lead PLEODRUG(TM) PXT3003 in PLOS ONE showing that early treatment with PXT3003 in a transgenic rat model delays the onset of Charcot-Marie-Tooth disease Type 1A (CMT1A).

January 17, 2019
·
6 min read
Pharm Country

Novel Oral Antibiotic Treatment Seysaratm (Sarecycline) Now Available

Seysara is a novel oral antibiotic developed specifically for acne

January 17, 2019
·
9 min read